Thank you for the information.

First 7 Last

Share
Profile

Follow
dingodoggy

77 Posts.

43

13/03/23

13:39

Post #: 66734974
Share

Originally posted by MinerBrad: ↑

Hi dingodoggy,

I agree, the report doesn’t seem to give us much to go on. For me, what’s enticing is the prospect of a significant find of REE, including Nd in the rims of the Carbonatites.
The last drill program was exciting because we had mineralised outcropping with extremely high percentage of Neodymium, similar or higher than Hastings. But, we didn’t have the significant magnetics coming near surface that LI-01 and LI-03 have. The share price shot up pre-results. But sadly the thicknesses were narrow and the grade was lower than were hoped for.

Now, for me, we’re coming up to the exciting bit. We have some different data that gives hope of covering the missing variables from the last. We have magnetics showing the Carbonatite pushing nearly to surface and the past drilling shows what’s coming up from these sources is
miralised (it doesn’t need to be their dykes, like DRE have found). But, we don’t have the outcropping to give us an idea of what is there.

The valuable mineralisation of REE come from late-stage pulses of the Carbonatite source. To me, common sense is showing that that is what’s happening in LI-03 and LI-01. Surely this was the same case with the mineralisation coming from LI-05 which we found in the last drill program. This time we have the magnetics giving confidence that it’s larger.

It’s a frustrating time for the markets and I’m not too impressed by what could be dodgy mgmt, but I’m here for the geology.

Expand

Thank you for the information.

LNR Price at posting: 1.6¢ Sentiment: None Disclosure: Not Held
2 Upvote

0 Great analysis

Reply

Top Stories

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

First 7 Last

Add LNR (ASX) to my watchlist

(20min delay)
Last 0.3¢		Change 0.000(0.00%)		Mkt cap ! $7.330M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
10	18190191	0.3¢

Sellers (Offers)

Price($)	Vol.	No.
0.4¢	21462964	28

View Market Depth

No.	Vol.	Price($)
10	18190191	0.003
53	59144228	0.002
21	96423078	0.001
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.004	21462964	28
0.005	10435725	13
0.006	18111224	15
0.007	30151463	14
0.008	3970000	8

Last trade - 16.12pm 07/10/2024 (20 minute delay)

LNR (ASX) Chart

Day chart unavailable

Thank you for the information.

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Thank you for the information.

Top Stories

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News